Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2020 2021/C 324/10 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee
Date: 2021-08-12
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, European Economic Area, free movement of goods, market approval, medicinal product, withdrawal from the market








C_2021324EN.01001601.xml










12.8.2021   


EN


Official Journal of the European Union


C 324/16






Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2020
(2021/C 324/10)
Subcommittee I on the free movement of goods
To be noted by the EEA Joint Committee
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July – 31 December 2020, at their meeting on 19 March 2021:







Annex I

List of new marketing authorisations











Annex II

List of renewed marketing authorisations











Annex III

List of extended marketing authorisations











Annex IV

List of withdrawn marketing authorisations











Annex V

List of suspended marketing authorisations








ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July – 31 December 2020:








EU-Number


Product


Country


Date of authorisation




EU/1/20/1476


Adakveo


Iceland


6.11.2020




EU/1/20/1476


Adakveo


Norway


5.11.2020




EU/1/20/1458


Apixaban Accord


Iceland


10.8.2020




EU/1/20/1458


Apixaban Accord


Liechtenstein


31.8.2020




EU/1/20/1458


Apixaban Accord


Norway


10.8.2020




EU/1/20/1469


Arikayce liposomal


Norway


2.11.2020




EU/1/20/1469


Arikayce liposomal


Iceland


5.11.2020




EU/1/20/1475


Arsenic trioxide medac


Iceland


14.10.2020




EU/1/20/1475


Arsenic trioxide medac


Norway


29.9.2020




EU/1/20/1454


Aybintio


Iceland


25.8.2020




EU/120/1454


Aybintio


Liechtenstein


31.8.2020




EU/1/20/1454


Aybintio


Norway


25.8.2020




EU/1/20/1473


AYVAKYT


Iceland


14.10.2020




EU/1/20/1473


Ayvakyt


Norway


29.9.2020




EU/1/17/1214


Bavencio


Liechtenstein


31.8.2020




EU/1/20/1474


Blenrep


Iceland


14.9.2020




EU/1/20/1474


Blenrep


Liechtenstein


31.8.2020




EU/1/20/1474


Blenrep


Norway


2.9.2020




EU/1/19/1403


Budesonid/Formoterol Teva Pharma B.V.


Liechtenstein


31.8.2020




EU/1/20/1448


Cabazitaxel Accord


Iceland


3.9.2020




EU/1/20/1448


Cabazitaxel Accord


Norway


28.10.2020




EU/1/20/1479


Calquence


Iceland


10.11.2020




EU/1/20/1479


Calquence


Norway


11.11.2020




EU/2/20/264


Circomax Myco


Norway


16.12.2020




EU/1/20/1528


Comirnaty


Iceland


21.12.2020




EU/1/20/1528


Comirnaty


Norway


21.12.2020




EU/1/20/1451


Daurismo


Iceland


20.7.2020




EU/1/20/1451


Daurismo


Norway


3.7.2020




EU/1/20/1438


Enerzair Breezhaler


Iceland


21.7.2020




EU/1/20/1438


Enezair Breezhaler


Norway


14.7.2020




EU/2/20/262


Enteroporc Coli AC


Norway


16.12.2020




EU/1/20/1472


Equidacent


Iceland


14.10.2020




EU/1/20/1472


Equidacent


Norway


29.9.2020




EU/1/20/1489


Exparel liposomal


Iceland


3.12.2020




EU/1/20/1489


Exparel liposomal


Norway


24.11.2020




EU/1/20/1477


Fampridine Accord


Iceland


15.10.2020




EU/1/20/1477


Fampridine Accord


Norway


1.10.2020




EU/1/20/1450


Fingolimod Accord


Iceland


20.7.2020




EU/1/20/1450


Fingolimod Accord


Norway


13.7.2020




EU/1/20/1465


Gencebok


Iceland


25.8.2020




EU/1/20/1465


Gencebok


Liechtenstein


31.8.2020




EU/1/20/1465


Gencebok


Norway


2.9.2020




EU/1/20/1446


Hepcludex


Iceland


12.8.2020




EU/1/20/1446


Hepcludex


Liechtenstein


31.8.2020




EU/1/20/1446


Hepcludex


Norway


10.8.2020




EU/1/20/1471


Idefirix


Iceland


2.9.2020




EU/1/20/1471


Idefirix


Liechtenstein


31.8.2020




EU/1/20/1471


Idefirix


Norway


8.9.2020




EU/2/20/258


Increxxa


Iceland


21.9.2020




EU/2/20/256


Innovax-ND-ILT


Iceland


16.10.2020




EU/1/20/1447


Insulin Aspart Sanofi


Iceland


20.7.2020




EU/1/20/144


Insulin aspart Sanofi


Norway


3.7.2020




EU/1/20/1480


Jyseleca


Iceland


14.10.2020




EU/1/20/1480


Jyseleca


Norway


30.9.2020




EU/1/20/1468


Kaftrio


Iceland


25.8.2020




EU/1/20/1468


Kaftrio


Liechtenstein


31.8.2020




EU/1/20/1468


Kaftrio


Norway


3.9.2020




EU/1/20/1494


Leqvio


Norway


15.12.2020




EU/2/20/261


Librela


Iceland


13.11.2020




EU/1/20/1462


Livogiva


Iceland


2.9.2020




EU/1/20/1462


Livogiva


Liechtenstein


31.8.2020




EU/1/20/1462


Livogiva


Norway


7.9.2020




EU/1/20/1483


MenQuadfi


Iceland


2.12.2020




EU/1/20/1483


MenQuadfi


Norway


30.11.2020




EU/1/20/1470


Methylthioninium chloride Cosmo


Iceland


27.8.2020




EU/1/20/1470


Methylthioninium chloride Cosmo


Norway


3.9.2020




EU/2/20/259


Mhyosphere PCV ID


Iceland


14.10.2020




EU/2/19/247


Mirataz


Norway


11.8.2020




EU/1/20/1445


Mvabea


Iceland


21.7.2020




EU/1/20/1445


Mvabea


Norway


13.7.2020




EU/2/20/265


Nobivac DP PLUS


Norway


17.12.2020




EU/1/20/1424


Nustendi


Liechtenstein


31.8.2020




EU/1/20/1486


Nyvepria


Iceland


3.12.2020




EU/1/20/1486


Nyvepria


Norway


24.11.2020




EU/1/20/1485


Obiltoxaximab SFL


Iceland


8.12.2020




EU/1/20/1485


Obiltoxaximab SFL


Norway


24.11.2020




EU/2/20/260


OvuGel


Iceland


8.12.2020




EU/1/20/1496


Oxlumo


Iceland


2.12.2020




EU/1/20/1496


Oxlumo


Norway


24.11.2020




EU/1/20/1487


PHELINUN


Iceland


3.12.2020




EU/1/20/1487


PHELINUN


Norway


2.12.2020




EU/1/20/1497


Phesgo


Norway


23.12.2020




EU/1/20/1455


Piqray


Iceland


11.8.2020




EU/1/20/1455


Piqray


Liechtenstein


31.8.2020




EU/1/20/1455


Piqray


Norway


10.8.2020




EU/1/20/1437


Pretomanid FGK


Iceland


12.8.2020




EU/1/20/1437


Pretomanid FGK


Liechtenstein


31.8.2020




EU/1/20/1437


Pretomanid FGK


Norway


10.8.2020




EU/2/20/254


Prevexxion RN


Iceland


10.8.2020




EU/2/20/254


Prevexxion RN


Norway


10.8.2020




EU/2/20/255


Prevexxion RN+HVT+IBD


Iceland


27.7.2020




EU/2/20/255


Prevexxion RN+HVT+IBD


Liechtenstein


31.8.2020




EU/1/20/1463


Qutavina


Iceland


2.9.2020




EU/1/20/1463


Qutavina


Liechtenstein


31.8.2020




EU/1/20/1463


Qutavina


Norway


7.9.2020




EU/1/20/1452


Reblozyl


Iceland


20.7.2020




EU/1/20/1452


Reblozyl


Norway


3.7.2020




EU/2/20/263


Rexxolide


Norway


16.12.2020




EU/1/20/1488


Rivaroxaban Accord


Iceland


1.12.2020




EU/1/20/1488


Rivaroxaban Accord


Norway


2.12.2020




EU/1/20/1460


Rozlytrek


Iceland


12.8.2020




EU/1/20/1460


Rozlytrek


Norway


10.8.2020




EU/1/20/1484


Supemtek


Iceland


1.12.2020




EU/1/20/1484


Supemtek


Norway


24.11.2020




EU/1/20/1492


Tecartus


Norway


30.12.2020




EU/1/20/1498


TRIXEO AEROSPHERE


Norway


16.12.2020




EU/2/20/257


Tulinovet


Iceland


21.9.2020




EU/2/20/257


Tulinovet


Norway


8.12.2020




EU/1/20/1459


Veklury


Iceland


3.7.2020




EU1/20/1459


Veklury


Liechtenstein


31.8.2020




EU/1/20/1459


Veklury


Norway


3.7.2020




EU/1/20/1481


Vocabria


Norway


30.12.2020




EU/1/20/1457


Xenleta


Iceland


11.8.2020




EU/1/20/1457


Xenleta


Liechtenstein


31.8.2020




EU/1/20/1457


Xenleta


Norway


10.8.2020




EU/1/20/1444


Zabdeno


Iceland


21.7.2020




EU/1/20/1444


Zabdeno


Liechtenstein


31.8.2020




EU/1/20/1444


Zabdeno


Norway


14.7.2020




EU/1/20/1456


Zercepac


Iceland


11.8.2020




EU/1/20/1456


Zercepac


Liechtenstein


31.8.2020




EU/1/20/1456


Zercepac


Norway


10.8.2020




EU/1/20/1440


Zimbus Breezhaler


Iceland


21.7.2020




EU/1/20/1440


Zimbus Breezhaler


Liechtenstein


31.8.2020




EU/1/20/1440


Zimbus Breezhaler


Norway


13.7.2020




EU/1/20/1478


ZYNRELEF


Iceland


16.10.2020




EU/1/20/1478


Zynrelef


Norway


1.10.2020









ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July – 31 December 2020:








EU-Number


Product


Country


Date of authorisation




EU/1/12/794


ADCETRIS


Iceland


2.10.2020




EU/1/12/794


ADCETRIS


Liechtenstein


31.8.2020




EU/1/12/794


ADCETRIS


Norway


14.10.2020




EU/1/15/1045


Aripiprazole Accord


Iceland


15.10.2020




EU/1/15/1045


Aripiprazole Accord


Norway


9.10.2020




EU/1/15/1029


Aripiprazole Sandoz


Iceland


20.7.2020




EU/1/15/1029


Aripiprazole Sandoz


Norway


21.7.2020




EU/1/15/1063


Armisarte


Iceland


25.8.2020




EU/1/15/1063


Armisarte


Liechtenstein


31.8.2020




EU/1/15/1063


Armisarte


Norway


28.8.2020




EU/1/17/1214


Bavencio


Iceland


10.8.2020




EU/1/17/1214


Bavencio


Norway


25.8.2020




EU/1/15/1074


Benepali


Iceland


7.12.2020




EU/1/15/1074


Benepali


Norway


26.11.2020




EU/1/15/1073


Briviact


Iceland


19.10.2020




EU/1/15/1073


Briviact


Norway


20.10.2020




EU/2/15/183


Canigen L4


Iceland


26.8.2020




EU/1/15/1055


CIAMBRA


Iceland


11.8.2020




EU/1/15/1055


Ciambra


Norway


10.8.2020




EU/1/15/1054


Cinacalcet Mylan


Iceland


13.10.2020




EU/1/15/1054


Cinacalcet Mylan


Norway


1.10.2020




EU/1/15/1048


Cotellic


Iceland


17.7.2020




EU/1/15/1048


Cotellic


Norway


3.7.2020




EU/1/15/1036


CRESEMBA


Iceland


24.8.2020




EU/1/15/1036


Cresemba


Liechtenstein


31.8.2020




EU/1/15/1036


Cresemba


Norway


28.8.2020




EU/1/15/1028


Duloxetine Zentiva


Iceland


24.8.2020




EU/1/15/1028


Duloxetine Zentiva


Liechtenstein


31.8.2020




EU/1/15/1028


Duloxetine Zentiva


Norway


2.9.2020




EU/1/15/1051


Ebymect


Iceland


3.9.2020




EU/1/15/1051


Ebymect


Norway


7.9.2020




EU/1/15/1052


Edistride


Iceland


15.10.2020




EU/1/15/1052


Edistride


Norway


1.10.2020




EU/1/15/1046


Elocta


Iceland


25.8.2020




EU/1/15/1046


Elocta


Liechtenstein


31.8.2020




EU/1/15/1058


Entresto


Iceland


20.7.2020




EU/1/15/1058


Entresto


Norway


3.7.2020




EU/1/15/1069


Episalvan


Iceland


13.10.2020




EU/1/15/1069


Episalvan


Norway


7.10.2020




EU/1/15/1065


Eptifibatide Accord


Iceland


15.10.2020




EU/1/15/1065


Eptifibatide Accord


Norway


8.10.2020




EU/1/19/1392


Ervebo


Iceland


21.9.2020




EU1/19/1392


Ervebo


Liechtenstein


31.8.2020




EU/1/19/1392


Ervebo


Norway


21.9.2020




EU/1/15/1075


Feraccru


Iceland


10.12.2020




EU/1/15/1075


Feraccru


Norway


3.12.2020




EU/2/15/185


Fortekor Plus


Iceland


10.8.2020




EU/2/15/185


Fortekor Plus


Liechtenstein


31.8.2020




EU/2/15/185


Fortekor Plus


Norway


10.8.2020




EU/1/15/1061


Genvoya


Iceland


2.10.2020




EU/1/15/1061


Genvoya


Norway


29.9.2020




EU/1/11/677


Gilenya


Iceland


27.11.2020




EU/1/11/677


Gilenya


Norway


23.11.2020




EU/1/15/1008


Hetlioz


Iceland


20.7.2020




EU/1/15/1008


Hetlioz


Norway


13.7.2020




EU/1/15/1064


Imlygic


Iceland


7.12.2020




EU/1/15/1064


Imlygic


Norway


23.11.2020




EU/2/15/193


Imrestor


Iceland


16.10.2020




EU/2/15/193


Imrestor


Norway


9.10.2020




EU/1/15/1040


Intuniv


Iceland


17.7.2020




EU/1/15/1040


Intuniv


Norway


3.7.2020




EU/1/11/676


Jevtana


Norway


22.12.2020




EU/1/15/1076


Kovaltry


Iceland


13.10.2020




EU/1/15/1076


Kovaltry


Norway


7.10.2020




EU/1/15/1060


Kyprolis


Iceland


17.7.2020




EU/1/15/1060


Kyprolis


Norway


3.7.2020




EU/1/15/1067


Lopinavir/Ritonavir Mylan


Iceland


27.11.2020




EU/1/15/1067


Lopinavir/Ritonavir Mylan


Norway


24.11.2020




EU/1/15/1078


Natpar


Norway


17.8.2020




EU/1/16/1094


Ninlaro


Iceland


7.12.2020




EU/2/15/186


Novaquin


Iceland


24.7.2020




EU/2/15/186


Novaquin


Norway


10.8.2020




EU/1/15/1043


Nucala


Iceland


24.8.2020




EU/1/15/1043


Nucala


Liechtenstein


31.8.2020




EU/1/15/1043


Nucala


Norway


19.8.2020




EU/1/15/1035


Obizur


Iceland


9.12.2020




EU/1/15/1035


Obizur


Norway


26.11.2020




EU/1/15/1018


Omidria


Iceland


10.8.2020




EU/1/15/1018


Omidria


Liechtenstein


31.8.2020




EU/1/15/1018


Omidria


Norway


10.8.2020




EU/1/15/1070


Oncaspar


Iceland


7.12.2020




EU/1/15/1070


Oncaspar


Norway


26.11.2020




EU/1/18/1345


Ondexxya


Norway


13.8.2020




EU/1/15/1059


Orkambi


Iceland


7.12.2020




EU/1/15/1059


Orkambi


Norway


23.11.2020




EU/1/15/1071


Pemetrexed Accord


Iceland


6.11.2020




EU1/15/1071


Pemetrexed Accord


Norway


9.10.2020




EU/1/15/1057


Pemetrexed Hospira


Iceland


14.8.2020




EU/1/15/1057


Pemetrexed Hospira


Norway


21.8.2020




EU/1/15/1038


Pemetrexed medac


Iceland


26.8.2020




EU/1/15/1038


Pemetrexed medac


Liechtenstein


31.8.2020




EU/1/15/1038


Pemetrexed medac


Norway


3.9.2020




EU/1/15/1037


Pemetrexed Sandoz


Iceland


31.8.2020




EU/1/15/1037


Pemetrexed Sandoz


Liechtenstein


31.8.2020




EU/1/15/1037


Pemetrexed Sandoz


Norway


3.9.2020




EU/1/19/1388


Polivy


Norway


17.12.2020




EU/1/15/1056


Praxbind


Iceland


11.8.2020




EU/1/15/1056


Praxbind


Liechtenstein


31.8.2020




EU/1/15/1056


Praxbind


Norway


10.8.2020




EU/1/15/1027


Pregabalin Accord


Iceland


20.7.2020




EU/1/15/1027


Pregabalin Accord


Liechtenstein


31.8.2020




EU/1/15/1027


Pregabalin Accord


Norway


14.7.2020




EU/1/15/1011


Pregabalin Sandoz


Iceland


17.7.2020




EU/1/15/1011


Pregabalin Sandoz


Norway


13.7.2020




EU/1/15/1012


Pregabalin Sandoz GmbH


Iceland


17.7.2020




EU/1/15/1012


Pregabalin Sandoz GmbH


Norway


13.7.2020




EU/1/10/618


Prolia


Norway


14.8.2020




EU/1/16/1090


Rasagiline Mylan


Iceland


9.12.2020




EU/1/16/1090


Rasagiline Mylan


Norway


26.11.2020




EU/1/15/1062


Ravicti


Iceland


27.8.2020




EU/1/15/1062


Ravicti


Liechtenstein


31.8.2020




EU/1/15/1062


Ravicti


Norway


3.9.2020




EU/1/15/1020


Raxone


Iceland


14.8.2020




EU/1/15/1020


Raxone


Liechtenstein


31.8.2020




EU/1/15/1020


Raxone


Norway


19.8.2020




EU/2/15/191


Simparica


Iceland


26.8.2020




EU/2/15/191


Simparica


Liechtenstein


31.8.2020




EU/2/15/191


Simparica


Norway


2.9.2020




EU/1/15/1072


Spectrila


Iceland


15.10.2020




EU/1/15/1072


Spectrila


Norway


29.9.2020




EU/2/15/190


Suvaxyn Circo + MH RTU


Iceland


21.9.2020




EU/2/15/190


Suvaxyn Circo + MH RTU


Liechtenstein


31.8.2020




EU/2/15/190


Suvaxyn Circo + MH RTU


Norway


29.9.2020




EU/1/13/902


Translarna


Iceland


11.8.2020




EU/1/13/902


Translarna


Norway


20.8.2020




EU/2/15/184


UpCard


Iceland


17.7.2020




EU/2/15/184


Upcard


Norway


3.7.2020




EU/1/15/1083


Uptravi


Norway


21.12.2020




EU/1/15/1079


VAXELIS


Iceland


13.10.2020




EU/1/15/1079


Vaxelis


Norway


15.10.2020




EU/2/15/188


Vectormune ND


Liechtenstein


31.8.2020




EU/2/15/188


Vectormune ND


Norway


29.7.2020




EU/1/19/1385


VITRAKVI


Iceland


28.8.2020




EU/1/19/1385


VITRAKVI


Liechtenstein


31.8.2020




EU/1/19/1385


VITRAKVI


Norway


7.9.2020




EU/1/11/710


Votubia


Iceland


10.8.2020




EU/1/11/710


Votubia


Liechtenstein


31.8.2020




EU/1/11/710


Votubia


Norway


10.8.2020




EU/1/10/646


VPRIV


Iceland


10.8.2020




EU/1/10/646


VPRIV


Liechtenstein


31.8.2020




EU/1/10/646


VPRIV


Norway


10.8.2020




EU/1/15/1042


Zalviso


Iceland


15.10.2020




EU/1/15/1042


Zalviso


Norway


7.10.2020




EU/1/16/1093


Zonisamide Mylan


Norway


15.12.2020




EU/2/15/189


Zycortal


Iceland


27.8.2020




EU/2/15/189


Zycortal


Liechtenstein


31.8.2020




EU/2//15/189


Zycortal


Norway


3.9.2020









ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July – 31 December 2020:








EU-Number


Product


Country


Date of authorisation




EU/1/14/980/008-011


Cosentyx


Iceland


9.12.2020




EU/1/14/980/008-011


Cosentyx


Norway


30.11.2020




EU/1/16/1116/002


Epclusa


Iceland


31.8.2020




EU/1/16/1116/002


Epclusa


Norway


3.9.2020




EU/1/14/958/003-005


Harvoni


Iceland


21.7.2020




EU/1/14/958


Harvoni


Norway


14.7.2020




EU/1/16/1095/009


IDELVION


Iceland


27.8.2020




EU/1/16/1095/009


IDELVION


Norway


3.9.2020




EU/1/12/782/007


Kalydeco


Iceland


9.12.2020




EU/1/12/782


Kalydeco


Norway


25.11.2020




EU/1/15/1071/004-007


Pemetrexed Accord


Iceland


8.12.2020




EU/1/15/1071


Pemetrexed Accord


Norway


16.11.2020




EU/1/15/1057/004-006


Pemetrexed Hospira


Iceland


15.10.2020




EU/1/15/1057


Pemetrexed Hospira


Norway


30.9.2020




EU/1/14/934


Plegridy


Norway


14.12.2020




EU/1/15/1031/019-020


Praluent


Iceland


24.8.2020




EU/1/13/894/003-005


Sovaldi


Iceland


20.7.2020




EU/1/13/894


Sovaldi


Norway


3.7.2020




EU/1/06/359/007-018


Suboxone


Iceland


21.7.2020




EU/1/06/359/007-018


Suboxone


Norway


17.7.2020




EU/1/18/1306/002


Symkevi


Iceland


9.12.2020




EU/1/18/1306


Symkevi


Norway


25.11.2020




EU/1/14/956/011-016


Trulicity


Iceland


9.12.2020




EU/1/14/956/011-016


Trulicity


Norway


2.12.2020




EU/1/19/1371/002-003


Ultomiris


Iceland


3.12.2020




EU/1/19/1371/002-003


Ultomiris


Norway


25.11.2020




EU/1/14/943/005


Velphoro


Iceland


27.11.2020




EU/1/14/943/005


Velphoro


Norway


23.11.2020









ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July – 31 December 2020:








EU-Number


Product


Country


Date of withdrawal




EU/1/18/1269


Alpivab


Iceland


9.12.2020




EU/1/18/1269


Alpivab


Norway


10.12.2020




EU/1/10/623


Clopidogrel/Acetylsalicylic acid Zentiva


Iceland


14.8.2020




EU/1/18/1300


Duzallo


Iceland


11.8.2020




EU/1/18/1300


Duzallo


Norway


10.9.2020




EU/1/13/895


Kolbam


Iceland


20.7.2020




EU/1/13/895


Kolbam


Norway


11.8.2020




EU/1/00/149


Panretin


Iceland


13.11.2020




EU/1/19/1401


Qtrilmet


Iceland


24.8.2020




EU/1/19/1401


Qtrilmet


Liechtenstein


31.8.2020




EU/1/19/1401


Qtrilmet


Norway


8.10.2020




EU/1/20/1463


Qutavina


Iceland


10.12.2020




EU/1/20/1463


Qutavina


Norway


18.12.2020




EU/1/10/634


Ribavirin Mylan


Iceland


5.11.2020




EU/1/10/634


Ribavirin Mylan


Norway


5.11.2020




EU/1/07/388


Sebivo


Iceland


27.11.2020




EU/1/07/388


Sebivo


Norway


23.11.2020




EU/2/09/099


Suvaxyn PCV


Iceland


24.7.2020




EU/1/12/752


Vepacel


Iceland


14.10.2020




EU/1/12/752


Vepacel


Norway


8.10.2020




EU/1/96/009


Zerit


Iceland


17.7.2020




EU/1/96/009


Zerit


Norway


8.7.2020




EU/2/09/105


Zulvac 8 Bovis


Iceland


12.11.2020




EU/2/09/105


Zulvac 8 Bovis


Norway


11.11.2020




EU/1/15/1080


Zurampic


Iceland


12.8.2020




EU/1/15/1080


Zurampic


Liechtenstein


31.8.2020




EU/1/15/1080


Zurampic


Norway


10.9.2020









ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July – 31 December 2020:








EU-Number


Product


Country


Date of suspension




EU/1/12/750


Esmya


Iceland


26.8.2020




EU/1/18/1309


Ulipristal Acetate Gedeon Richter 5


Iceland


26.8.2020